Immune aging and treatment outcomes in older adults with IBD
Part of Digestive system clinical trials.
This study looks at how the immune system ages in people over 60 with inflammatory bowel disease (IBD) and how well newer treatments work for them. It aims to find out if immune aging affects treatment success.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years old or older.
- You have a confirmed diagnosis of Crohn's disease, ulcerative colitis, or inflammatory bowel disease unclassified.
- You are about to start a new advanced therapy, or you started one within the last 4 weeks.
- You have active IBD symptoms or a medical reason to increase treatment.
- You can provide your medical history and blood test results needed for the study.
- You can commit to follow-up for at least 52 weeks and give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system works in older adults and how it relates to infections. It aims to develop better ways to prevent and manage infectious diseases in people over 60.
This study is looking at how infections and the aging immune system affect older adults. It compares people with an infection to healthy volunteers to understand how the body fights germs as we age.
This study looks at how certain immune system markers, called inflammasomes, relate to frailty (physical weakness and vulnerability) in older adults who are candidates for kidney transplantation. The goal is to better understand these markers, which might help improve care for older transplant patients in the future.
This study looks at how inflammatory bowel disease (IBD) activity affects frailty in people over 60. It tests whether starting or changing medication for active IBD can help understand and manage frailty.
This study is looking at how the immune system works in people with inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis. By comparing blood or tissue samples from people with and without IBD, researchers hope to find better ways to treat the disease in the future.
This study collects blood and tissue samples to better understand how the immune system behaves in people with inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis. It aims to advance research rather than test a specific new treatment, and it also enrolls healthy volunteers for comparison.
Hear when a new Frailty trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.